Comment: Thiazolidinediones in type 2 diabetes: a cardiology perspective
Ann Pharmacother
.
2009 Feb;43(2):391-2; author reply 392-3.
doi: 10.1345/aph.1K666a.
Authors
Vijaya M Musini
,
Kenneth L Bassett
,
Aaron M Tejani
PMID:
19193598
DOI:
10.1345/aph.1K666a
No abstract available
Publication types
Comment
Letter
MeSH terms
Cardiovascular Diseases / chemically induced*
Diabetes Mellitus, Type 2 / drug therapy*
Humans
Randomized Controlled Trials as Topic
Thiazolidinediones / adverse effects*
Substances
Thiazolidinediones